Greenray Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-12-2024
- Paid Up Capital ₹ 0.40 M
as on 03-12-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2010
About Greenray Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Ayub Saha, Khalik Saha, Mir Shahiruddin, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290OR2009PTC010976
- Company No.
010976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2009
- Date of AGM
30 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Baleswar, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Greenray Pharmaceutical?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mir Shahiruddin | Managing Director | 23-Jul-2009 | Current |
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ayub Saha | Director | 23-Jul-2009 | Current |
Khalik Saha | Director | 23-Jul-2009 | Current |
Mir Tahiruddin | Director | 23-Jul-2009 | Current |
Financial Performance of Greenray Pharmaceutical.
Enhance accessibility to Greenray Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Greenray Pharmaceutical?
Unlock access to Greenray Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Green Ray Foods & Nutrients Private LimitedActive 14 years 7 months
Ayub Saha, Khalik Saha and 2 more are mutual person
- Gemini Cosmetics Private LimitedActive 18 years 10 months
Ayub Saha, Khalik Saha and 2 more are mutual person
- Green Ray Allied Chemicals LimitedActive 12 years 11 months
Ayub Saha, Khalik Saha and 2 more are mutual person
- Green Ray International LimitedActive 20 years 11 days
Ayub Saha, Khalik Saha and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Greenray Pharmaceutical?
Unlock and access historical data on people associated with Greenray Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenray Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenray Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.